Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy

MAHAD, D. J., HOWELL, S. J. L. and WOODROOFE, N. (2002). Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy. Journal of neurology neurosurgery and psychiatry, 73 (3), 320-323.

Full text not available from this repository.
Link to published version:: https://doi.org/10.1136/jnnp.73.3.320
Related URLs:

    Abstract

    Chemokines are likely to contribute to the pathogenesis of chronic inflammatory demyelinating polyneuropathy (CIDP), as evidenced by data from experimental autoimmune neuritis. The and ß chemokines in the cerebrospinal fluid (CSF) and serum from patients with CIDP were analysed using an enzyme linked immunosorbent assay. CXCL9, CXCL10, and CCL3 were raised in the CSF in CIDP compared with controls and non-demyelinating neuropathies (p < 0.001). Although the CSF levels of CCL2 were significantly higher than the serum levels for all groups, the difference between groups was not significant. CXCL9, CXCL10, and CCL3 may contribute to the pathogenesis of CIDP by recruiting inflammatory T cells and monocytes to spinal nerve roots, while CCL2 is likely to play a physiological role.

    Item Type: Article
    Uncontrolled Keywords: chemokines, chronic inflammatory demyelinating polyneuropathy
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomolecular Sciences Research Centre
    Identification Number: https://doi.org/10.1136/jnnp.73.3.320
    Page Range: 320-323
    Depositing User: Ann Betterton
    Date Deposited: 13 Feb 2008
    Last Modified: 13 Jun 2017 12:44
    URI: http://shura.shu.ac.uk/id/eprint/429

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics